News

STOP's monthly newsletter is packed with insights from experts in obesity prevention and treatment, details on upcoming events, and exciting news from our member organizations. The opening Letter from the Director is posted 

Recent Letters from the Director

 

April 2025 Letter from the Director

Guest Letter: Concerns About Compounded GLP-1 Medications

Concerns About Compounded GLP-1 Medications

April 29, 2025

OAC has long advised our members against using compounded GLP-1’s. The main reason is FDA’s own words about compounding.

March 2025 Letter from the Director

FDA's New Draft Guidance for Obesity Medications

FDA's New Draft Guidance for Obesity Medications

March 31, 2025

This past January the FDA published a draft guidance entitled “Obesity and Overweight: Developing Drugs and Biological Products for Weight Reduction.”

Feb 2025 Letter from the Director

Obesity Care Week 2025

Obesity Care Week 2025

February 28, 2025

OCW's theme this year is “Commit to Care,” to encourage everyone to advocate for accessible, affordable, respectful, and compassionate obesity care.

 

Read Past Letters from the Director 

 

Newsletter icon

Sign up for the monthly STOP Newsletter

Subscribe below to receive STOP's monthly email packed with insights from experts in obesity prevention and treatment, details on upcoming events, and exciting news from our member organizations!

* indicates required